Clarityn Allergy Relief

Clarityn, widely known as Claritin in many markets, is one of the world's most recognized over-the-counter allergy medications. Its active ingredient, Loratadine, was first developed to provide long-lasting relief from hay fever and other allergy symptoms without the sedative effects commonly associated with older antihistamines. The brand has become a staple in consumer healthcare for its 24-hour non-drowsy efficacy.

The brand's journey involves significant corporate acquisitions within the pharmaceutical industry. Originally a product of Schering-Plough, a major American pharmaceutical firm, the brand saw a shift in ownership when Schering-Plough merged with Merck & Co. (known as MSD outside the US). Later, the consumer health portfolio, including Clarityn, was acquired by the German life sciences giant Bayer AG. This move solidified Bayer's position as a global leader in over-the-counter medications.

Today, Clarityn is manufactured across a global supply chain to meet international demand. Bayer oversees the production and distribution through various regional subsidiaries. While the brand originated in the United States, its current strategic and corporate home is in Germany, where its ultimate owner, Bayer AG, is headquartered.